indiabrand.org 
The combination of dapagliflozin and sitagliptin is marketed under the brand name "Xigduo". This medication is used for the management of type 2 diabetes mellitus. In India, Xigduo supports glycemic control by combining the mechanisms of an SGLT2 inhibitor with a DPP-4 inhibitor. You can consult healthcare providers for more personalized information regarding its use.
Brands to consider
Glyxambi
Glyxambi combines dapagliflozin and sitagliptin, offering a dual mechanism for managing type 2 diabetes effectively. This combination enhances glycemic control by targeting both insulin sensitivity and eliminating excess glucose through urine. Many people in India seek this option due to its potential to improve overall metabolic health and simplify treatment regimens. With its efficacy backed by clinical studies, Glyxambi is becoming a noteworthy choice for diabetes management in the Indian healthcare landscape.
Qtern
Qtern is a combination medication featuring dapagliflozin and sitagliptin, effectively used for managing type 2 diabetes in India. Dapagliflozin, as an SGLT2 inhibitor, aids in lowering blood sugar levels by promoting glucose excretion through urine, while sitagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces hepatic glucose production. This synergy can lead to improved glycemic control and potential weight loss benefits. Patients may appreciate the convenience of a single pill, simplifying their diabetes management routine.
Sintaglipt
Sintaglipt is a notable combination medication of dapagliflozin and sitagliptin available in India, primarily targeting type 2 diabetes management. Dapagliflozin functions by inhibiting glucose reabsorption in the kidneys, promoting glucose excretion through urine, while sitagliptin increases incretin levels to enhance insulin secretion. This dual-action approach effectively helps regulate blood sugar levels and improve glycemic control. Patients may find Sintaglipt beneficial due to its comprehensive mechanism addressing different pathways in diabetes management. You may want to discuss this option with your healthcare provider for personalized advice.
Galvus Duo
Galvus Duo is a combination of dapagliflozin and sitagliptin, specifically formulated for managing type 2 diabetes in India. This dual-action medication works by increasing insulin production and reducing glucose absorption, aiding in effective blood sugar control. Patients may experience fewer side effects compared to single-agent treatments, enhancing their adherence to diabetes management plans. With its fixed-dose combination, Galvus Duo offers convenience and may simplify the treatment regimen for individuals struggling with diabetes. Consult your healthcare provider to determine if Galvus Duo aligns with your health goals.
Trajenta Duo
Trajenta Duo combines dapagliflozin and sitagliptin, making it a potent option for managing Type 2 diabetes in India. This formulation effectively lowers blood sugar levels by enhancing insulin sensitivity and reducing glucose reabsorption in the kidneys. Patients may benefit from the dual action, potentially leading to improved glycemic control. As a brand under the trusted pharmaceutical companies, Trajenta Duo may also provide added convenience with its single-tablet regimen. Your healthcare provider can guide you on its suitability for your diabetes management.
Combination Benefits
Dapagliflozin and sitagliptin are combined in the brand name "Xigduo" in India, offering a dual mechanism for managing type 2 diabetes. This combination helps in lowering blood glucose levels by increasing urinary glucose excretion and enhancing insulin secretion. Patients using this combination may observe improved glycemic control along with potential weight loss benefits. Monitoring kidney function is advised when using Xigduo, as both components can influence renal health. You might also consider lifestyle changes to optimize therapy outcomes.
Usage Instructions
Dapagliflozin and sitagliptin, sold under the brand name Kombiglyze XR in India, is used for managing type 2 diabetes. You should take this medication as prescribed by your healthcare provider, usually once a day, with or without food. It is important to monitor your blood sugar levels regularly to ensure proper management of your diabetes. Possible side effects may include gastrointestinal issues, urinary tract infections, and dehydration, so maintaining adequate hydration is recommended. Consult your doctor for any questions regarding dosage or potential interactions with other medications.
Side Effects
Dapagliflozin and sitagliptin, often combined in medications like Xigduo, may lead to several side effects. Common occurrences include gastrointestinal issues such as nausea, diarrhea, and abdominal pain. Urogenital infections are also noted, particularly yeast infections in women. You should be aware of potential hypoglycemia when combined with other diabetes medications. Other side effects might include headache or dizziness, prompting a review of your treatment plan with a healthcare provider.
Prescription Guidelines
Dapagliflozin and sitagliptin, marketed under various brand names in India, are commonly prescribed for managing type 2 diabetes. These medications work synergistically to lower blood sugar levels, with dapagliflozin acting as a sodium-glucose co-transporter 2 (SGLT2) inhibitor and sitagliptin serving as a DPP-4 inhibitor. When prescribing this combination, healthcare providers typically assess factors such as renal function, current medication regimen, and potential side effects. Regular monitoring of glycemic control, along with patient education about lifestyle modifications, is advisable for optimal results.
Availability and Pricing
Dapagliflozin and sitagliptin are available in India under the brand name "Xigduo." This combination focuses on managing type 2 diabetes effectively. You may find the pricing for Xigduo varies across pharmacies, typically ranging from Rs1,500 to Rs2,500 for a month's supply. Availability can fluctuate based on different regions, but major cities and major chains are likely to stock it. Always consult with a healthcare professional for guidance on obtaining this medication.